Skip to main content
×
Home
    • Aa
    • Aa

Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update

  • Erik R. Dubberke (a1), Philip Carling (a2), Ruth Carrico (a3), Curtis J. Donskey (a4), Vivian G. Loo (a5), L. Clifford McDonald (a6), Lisa L. Maragakis (a7), Thomas J. Sandora (a8), David J. Weber (a9), Deborah S. Yokoe (a10) and Dale N. Gerding (a11)...
Abstract
Copyright
Corresponding author
Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St. Louis, MO 63110 (edubberk@dom.wustl.edu).
Footnotes
Hide All

Infect Control Hosp Epidemiol 2014;35(6):628-645

Footnotes
References
Hide All
, , , et al. . ;(suppl 1):S81–S92.1. ER Dubberke DN Gerding D Classen Strategies to prevent infections in acute care hospitalsClostridium difficile Infect Control Hosp Epidemiol 2008 29

, , , et al. .” ;():–.2. DS Yokoe DJ Anderson SM Berenholtz Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates Infect Control Hosp Epidemiol 2014 35 5 455459

, , . . ;():–.3. LC McDonald M Owings DB Jernigan infection in patients discharged from US short-stay hospitals, 1996–2003Clostridium difficile Emerg Infect Dis 2006 12 3 409415

, , , . . ;():–.4. BA Miller LF Chen DJ Sexton DJ Anderson Comparison of the burdens of hospital-onset, healthcare facility–associated infection and of healthcare-associated infection due to methicillin-resistant in community hospitalsClostridium difficileStaphylococcus aureus Infect Control Hosp Epidemiol 2011 32 4 387390

, , . . ;():–.5. MD Zilberberg AF Shorr MH Kollef Growth and geographic variation in hospitalizations with resistant infections, United States, 2000–2005 Emerg Infect Dis 2008 14 11 17561758

, , , et al. . ;():–.7. MP Bauer DW Notermans BH van Benthem infection in Europe: a hospital-based surveyClostridium difficile Lancet 2011 377 9759 6373

, , , et al. . ;():–.8. VG Loo L Poirier MA Miller A predominantly clonal multi-institutional outbreak of –associated diarrhea with high morbidity and mortalityClostridium difficile N Engl J Med 2005 353 23 24422449

, , , et al. . ;():–.9. M Miller D Gravel M Mulvey Health care–associated infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortalityClostridium difficile Clin Infect Dis 2010 50 2 194201

, , , et al. . ;():–.10. DM Denno N Shaikh JR Stapp Diarrhea etiology in a pediatric emergency department: a case control study Clin Infect Dis 2012 55 7 897904

, , , . . ;():–.11. RE Feghaly JL Stauber PI Tarr DB Haslam Viral co-infections are common and are associated with higher bacterial burden in children with infectionClostridium difficile J Pediatr Gastroenterol Nutr 2013 57 6 813816

, , , , , . . ;():–.12. C Rousseau I Poilane L De Pontual AC Maherault A Le Monnier A Collignon carriage in healthy infants in the community: a potential reservoir for pathogenic strainsClostridium difficile Clin Infect Dis 2012 55 9 12091215

, , , , , . . ;():–.15. ER Dubberke KA Reske Y Yan MA Olsen LC McDonald VJ Fraser –associated disease in a setting of endemicity: identification of novel risk factorsClostridium difficile Clin Infect Dis 2007 45 12 15431549

, , , et al. . ;():–.17. J Kim JF Shaklee S Smathers Risk factors and outcomes associated with severe infection in childrenClostridium difficile Pediatr Infect Dis J 2012 31 2 134138

, , , et al. . ;():–.19. LC McDonald GE Killgore A Thompson An epidemic, toxin gene–variant strain of Clostridium difficile N Engl J Med 2005 353 23 24332441

, , , . . ;():e24894.20. DA Burns D Heeg ST Cartman NP Minton Reconsidering the sporulation characteristics of hypervirulent BI/NAP1/027Clostridium difficile PLoS ONE 2011 6 9

, , , et al. . ;():–.21. M Merrigan A Venugopal M Mallozzi Human hypervirulent strains exhibit increased sporulation as well as robust toxin productionClostridium difficile J Bacteriol 2010 192 19 49044911

, , , et al. . ;():–.22. M Warny J Pepin A Fang Toxin production by an emerging strain of associated with outbreaks of severe disease in North America and EuropeClostridium difficile Lancet 2005 366 9491 10791084

, , , et al. . ;():–.23. AS Walker DW Eyre DH Wyllie Relationship between bacterial strain type, host biomarkers, and mortality in infectionClostridium difficile Clin Infect Dis 2013 56 11 15891600

, , , et al. . ;():–.25. AK Cheknis SP Sambol DM Davidson Distribution of strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005–2007Clostridium difficile Anaerobe 2009 15 6 230233

, , , et al. . ;():–.27. ER Dubberke AM Butler KA Reske Attributable outcomes of endemic –associated disease in nonsurgical patientsClostridium difficile Emerg Infect Dis 2008 14 7 10311038

, . . ;(suppl 2):S88–S92.28. ER Dubberke MA Olsen Burden of on the healthcare systemClostridium difficile Clin Infect Dis 2012 55

, , , , . . ;():–.29. AJ Hall AT Curns LC McDonald UD Parashar BA Lopman The roles of and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007Clostridium difficile Clin Infect Dis 2012 55 2 216223

, , , , . . ;():–.30. JS Sammons R Localio R Xiao SE Coffin T Zaoutis infection is associated with increased risk of death and prolonged hospitalization in childrenClostridium difficile Clin Infect Dis 2013 57 1 18

, , , et al. . ;():–.31. J Pepin N Saheb MA Coulombe Emergence of fluoroquinolones as the predominant risk factor for –associated diarrhea: a cohort study during an epidemic in QuebecClostridium difficile Clin Infect Dis 2005 41 9 12541260

, , , . . ;():–.32. S Dial JA Delaney AN Barkun S Suissa Use of gastric acid–suppressive agents and the risk of community-acquired –associated diseaseClostridium difficile JAMA 2005 294 23 29892995

, , , , , . . ;():–.33. J Belmares DN Gerding JP Parada S Miskevics F Weaver S Johnson Outcome of metronidazole therapy for disease and correlation with a scoring systemClostridium difficile J Infect 2007 55 6 495501

, , , et al. . ;():–.34. DM Musher S Aslam N Logan Relatively poor outcome after treatment of colitis with metronidazoleClostridium difficile Clin Infect Dis 2005 40 11 15861590

, , , . . ;():–.35. FA Zar SR Bakkanagari KM Moorthi MB Davis A comparison of vancomycin and metronidazole for the treatment of –associated diarrhea, stratified by disease severityClostridium difficile Clin Infect Dis 2007 45 3 302307

, , . . ;(suppl ):–.36. EJ Kuijper B Coignard P Tull Emergence of –associated disease in North America and EuropeClostridium difficile Clin Microbiol Infect 2006 12 6 218

, , , et al. . ;():–.38. ER Dubberke Z Han L Bobo Impact of clinical symptoms on interpretation of diagnostic assays for infectionsClostridium difficile J Clin Microbiol 2011 49 8 28872893

, , . . ;():–.39. J Pepin L Valiquette B Cossette Mortality attributable to nosocomial –associated disease during an epidemic caused by a hypervirulent strain in QuebecClostridium difficile CMAJ 2005 173 9 10371042

, , , et al. . ;():–.41. Y Longtin S Trottier G Brochu Impact of the type of diagnostic assay on infection and complication rates in a mandatory reporting programClostridium difficile Clin Infect Dis 2013 56 1 6773

, , , et al. . ;():–.42. TD Planche KA Davies PG Coen Differences in outcome according to testing method: a prospective multicentre diagnostic validation study of C difficile infectionClostridium difficile Lancet Infect Dis 2013 13 11 936945

, , , . . ;():–.43. ER Dubberke KA Reske LC McDonald VJ Fraser ICD-9 codes and surveillance for –associated diseaseClostridium difficile Emerg Infect Dis 2006 12 10 15761579

, , , , , . . ;():–.46. CR Polage DL Chin JL Leslie J Tang SH Cohen JV Solnick Outcomes in patients tested for toxinsClostridium difficile Diagn Microbiol Infect Dis 2012 74 4 369373

, , . . ;():–.49. MP Bauer EJ Kuijper JT van Dissel European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for infection (CDI)Clostridium difficile Clin Microbiol Infect 2009 15 12 10671079

, , , et al. . ;():–.51. CM Surawicz LJ Brandt DG Binion Guidelines for diagnosis, treatment, and prevention of infectionsClostridium difficile Am J Gastroenterol 2013 108 4 478498

, , , et al. . ;():–.53. SP Stone BS Cooper CC Kibbler The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection Lancet Infect Dis 2007 7 4 282288

, , , et al. . ;():–.54. S Fowler A Webber BS Cooper Successful use of feedback to improve antibiotic prescribing and reduce infection: a controlled interrupted time seriesClostridium difficile J Antimicrob Chemother 2007 59 5 990995

, , , , . . ;(suppl ):–.55. L Valiquette B Cossette MP Garant H Diab J Pepin Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of –associated disease caused by the hypervirulent NAP1/027 strainClostridium difficile Clin Infect Dis 2007 45 2 S112S121

, , , et al. . ;():–.56. MA Aldeyab MP Kearney MG Scott An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of infection in hospital settingsClostridium difficile J Antimicrob Chemother 2012 67 12 29882996

, , , . . ;():–.57. MJ Talpaert RG Gopal BS Cooper P Wade Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of infectionClostridium difficile J Antimicrob Chemother 2011 66 9 21682174

, , , , , . . ;():–.58. DM Guerrero MM Nerandzic LA Jury S Jinno S Chang CJ Donskey Acquisition of spores on gloved hands after contact with the skin of patients with infection and with environmental surfaces in their roomsClostridium difficile Am J Infect Control 2012 40 6 556558

, , , . . ;():–.59. LV McFarland ME Mulligan RY Kwok WE Stamm Nosocomial acquisition of infectionClostridium difficile N Engl J Med 1989 320 4 204210

, , , , . . ;():–.63. RG Gopal A Jeanes M Osman C Aylott J Green Marketing hand hygiene in hospitals—a case study J Hosp Infect 2002 50 1 4247

, , , et al. . ;():–.66. N Knight T Strait N Anthony colitis: a retrospective study of incidence and severity before and after institution of an alcohol-based hand rub policyClostridium difficile Am J Infect Control 2010 38 7 523528

, , , , , . . ;():–.68. N Vernaz H Sax D Pittet P Bonnabry J Schrenzel S Harbarth Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile J Antimicrob Chemother 2008 62 3 601607

, . . ;():–.70. VT Chang K Nelson The role of physical proximity in nosocomial diarrhea Clin Infect Dis 2000 31 3 717722

, , , , . . ;():–.71. CR Clabots S Johnson MM Olson LR Peterson DN Gerding Acquisition of by hospitalized patients: evidence for colonized new admissions as a source of infectionClostridium difficile J Infect Dis 1992 166 3 561567

, , De, , . . ;():–.72. MH Samore L Venkataraman PC Girolami RD Arbeit AW Karchmer Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial diarrheaClostridium difficile Am J Med 1996 100 1 3240

, , , . . ;():–.74. JL Mayfield T Leet J Miller LM Mundy Environmental control to reduce transmission of Clostridium difficile Clin Infect Dis 2000 31 4 9951000

, , , , , . . ;():–.75. MH Wilcox WN Fawley N Wigglesworth P Parnell P Verity J Freeman Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of infectionClostridium difficile J Hosp Infect 2003 54 2 109114

. . ;():–.76. AE Simor Diagnosis, management, and prevention of infection in long-term care facilities: a reviewClostridium difficile J Am Geriatr Soc 2010 58 8 15561564

, , , et al. . ;():–.78. VG Loo AM Bourgault L Poirier Host and pathogen factors for infection and colonizationClostridium difficile N Engl J Med 2011 365 18 16931703

, , , . ? ;():–.79. SB Doernberg LG Winston DH Deck HF Chambers Does doxycycline protect against development of infectionClostridium difficile Clin Infect Dis 2012 55 5 615620

, , , , , . . ;():–.80. F Le V Arora DN Shah M Salazar HR Palmer KW Garey A real-world evaluation of oral vancomycin for severe infection: implications for antibiotic stewardship programsClostridium difficile Pharmacotherapy 2012 32 2 129134

, , , , . . ;():–.81. SE Harpe TJ Inocencio AL Pakyz MJ Oinonen RE Polk Characterization of continued antibacterial therapy after diagnosis of hospital-onset infection: implications for antimicrobial stewardshipClostridium difficile Pharmacotherapy 2012 32 8 744754

, , , et al. . ;():–.84. ER Dubberke KA Reske J Noble-Wang Prevalence of environmental contamination and strain variability in multiple health care facilitiesClostridium difficile Am J Infect Control 2007 35 5 315318

III, , , . . ;():–.85. DM Dumford MM Nerandzic BC Eckstein CJ Donskey What is on that keyboard? detecting hidden environmental reservoirs of during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strainsClostridium difficile Am J Infect Control 2009 37 1 1519

, , . . ;():–.86. AM Lewis J Gammon I Hosein The pros and cons of isolation and containment J Hosp Infect 1999 43 1 1923

, , . . ;():–.91. PC Carling MF Parry SM Von Beheren Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals Infect Control Hosp Epidemiol 2008 29 1 17

, , . . ;():–.93. MH Wilcox WN Fawley P Parnell Value of lysozyme agar incorporation and alkaline thioglycollate exposure for the environmental recovery of Clostridium difficile J Hosp Infect 2000 44 1 6569

, , , et al. . ;():–.100. C McNulty M Logan IP Donald Successful control of infection in an elderly care unit through use of a restrictive antibiotic policyClostridium difficile J Antimicrob Chemother 1997 40 5 707711

, , , , . . ;():–.101. SM Pear TH Williamson KM Bettin DN Gerding JN Galgiani Decrease in nosocomial –associated diarrhea by restricting clindamycin useClostridium difficile Ann Intern Med 1994 120 4 272277

, , , et al. . ;():–.102. S Johnson SR Homann KM Bettin Treatment of asymptomatic carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled trialClostridium difficile Ann Intern Med 1992 117 4 297302

, . . ;():–.103. KB Kirkland JM Weinstein Adverse effects of contact isolation Lancet 1999 354 9185 11771178

, , , . . ;():–.104. DJ Morgan DJ Diekema K Sepkowitz EN Perencevich Adverse outcomes associated with contact precautions: a review of the literature Am J Infect Control 2009 37 2 8593

, , , . . ;():–.105. S Saint LA Higgins BK Nallamothu C Chenoweth Do physicians examine patients in contact isolation less frequently? a brief report Am J Infect Control 2003 31 6 354356

, , . . ;():–.106. HT Stelfox DW Bates DA Redelmeier Safety of patients isolated for infection control JAMA 2003 290 14 18991905

, , . . ;():–.107. LV McFarland GW Elmer CM Surawicz Breaking the cycle: treatment strategies for 163 cases of recurrent diseaseClostridium difficile Am J Gastroenterol 2002 97 7 17691775

, , , . . ;( suppl 2):–.108. JD Siegel E Rhinehart M Jackson L Chiarello 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings Am J Infect Control 2007 35 10 S65S164

, , , et al. . ;:CD006095.109. JZ Goldenberg SS Ma JD Saxton Probiotics for the prevention of –associated diarrhea in adults and childrenClostridium difficile Cochrane Database Syst Rev 2013 5

, , , et al. . ;():–.110. BC Johnston SS Ma JZ Goldenberg Probiotics for the prevention of –associated diarrhea: a systematic review and meta-analysisClostridium difficile Ann Intern Med 2012 157 12 878888

, , , et al. . ;():–.113. SJ Allen K Wareham D Wang Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trialClostridium difficile Lancet 2013 382 9900 12491257

, , , et al. . ;():–.114. P Munoz E Bouza M Cuenca-Estrella fungemia: an emerging infectious diseaseSaccharomyces cerevisiae Clin Infect Dis 2005 40 11 16251634

, , , , , . . ;():–.116. SK Wong A Kneebone M Morgan CJ Henderson A Morgan B Jalaludin Surgical management of colorectal cancer in south-western Sydney 1997–2001: a prospective series of 1293 unselected cases from six public hospitals ANZ J Surg 2005 75 9 776782

, , , , . . ;():–.119. JE Farley D Doughman R Jeeva P Jeffries JM Stanley Department of Health and Human Services releases new immersive simulation experience to improve infection control knowledge and practices among health care workers and students Am J Infect Control 2012 40 3 258259

, , , . . ;(4 suppl 1):S11–S17.120. T Landers S Abusalem MB Coty J Bingham Patient-centered hand hygiene: the next step in infection prevention Am J Infect Control 2012 40

. ? ;(suppl ):–.121. ER Dubberke Prevention of healthcare-associated infection: what worksClostridium difficile Infect Control Hosp Epidemiol 2010 31 1 S38S41

, , , et al. . ;():–.122. GH Guyatt AD Oxman GE Vist GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 2008 336 7650 924926

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 119 *
Loading metrics...

Abstract views

Total abstract views: 342 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 18th October 2017. This data will be updated every 24 hours.